Tag: Atea


Roche cuts ties with Atea after COVID-19 pill’s trial failure

November 17, 2021

Via: Biopharma Dive

Roche’s seeming lack of confidence in the future of AT-527 appears to be weighing on investors. Atea shares, which soared above $88 in February 2021, dropped 20% to below $9 apiece in early trading Wednesday. Even if the drug succeeds […]